OncoCyte Corp (OCX)
2.70
-0.10
(-3.74%)
USD |
NASDAQ |
May 07, 09:44
OncoCyte Price: 2.70 for May 7, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 06, 2024 | 2.69 | 2.84 | 2.59 | 2.805 | 21842.00 |
May 03, 2024 | 2.80 | 2.80 | 2.625 | 2.66 | 15346.00 |
May 02, 2024 | 2.53 | 2.87 | 2.48 | 2.779 | 51822.00 |
May 01, 2024 | 2.56 | 2.57 | 2.50 | 2.55 | 4963.00 |
Apr 30, 2024 | 2.49 | 2.59 | 2.42 | 2.49 | 18088.00 |
Apr 29, 2024 | 2.45 | 2.56 | 2.39 | 2.525 | 33004.00 |
Apr 26, 2024 | 2.48 | 2.581 | 2.41 | 2.48 | 17697.00 |
Apr 25, 2024 | 2.45 | 2.49 | 2.350 | 2.44 | 26490.00 |
Apr 24, 2024 | 2.51 | 2.51 | 2.285 | 2.46 | 40610.00 |
Apr 23, 2024 | 2.45 | 2.553 | 2.45 | 2.455 | 22837.00 |
Apr 22, 2024 | 2.52 | 2.555 | 2.49 | 2.51 | 63036.00 |
Apr 19, 2024 | 2.54 | 2.55 | 2.49 | 2.50 | 53925.00 |
Apr 18, 2024 | 2.59 | 2.66 | 2.49 | 2.56 | 38158.00 |
Apr 17, 2024 | 2.74 | 2.74 | 2.58 | 2.59 | 35980.00 |
Apr 16, 2024 | 2.56 | 2.77 | 2.490 | 2.75 | 170984.0 |
Apr 15, 2024 | 2.59 | 2.638 | 2.510 | 2.53 | 110351.0 |
Apr 12, 2024 | 3.20 | 3.30 | 2.42 | 2.71 | 2.172M |
Apr 11, 2024 | 2.86 | 2.987 | 2.86 | 2.965 | 380935.0 |
Apr 10, 2024 | 2.907 | 2.907 | 2.907 | 2.907 | 364.00 |
Apr 09, 2024 | 2.91 | 2.91 | 2.91 | 2.91 | 878.00 |
Apr 08, 2024 | 2.91 | 2.945 | 2.85 | 2.90 | 1512.00 |
Apr 05, 2024 | 2.855 | 2.90 | 2.83 | 2.90 | 1123.00 |
Apr 04, 2024 | 2.84 | 2.94 | 2.84 | 2.94 | 2894.00 |
Apr 03, 2024 | 2.82 | 2.99 | 2.82 | 2.94 | 2681.00 |
Apr 02, 2024 | 2.85 | 2.93 | 2.82 | 2.93 | 3595.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.08
Minimum
Nov 08 2023
130.00
Maximum
Feb 16 2021
36.96
Average
31.40
Median
Oct 28 2019
Price Benchmarks
Fonar Corp | 17.61 |
XWELL Inc | 1.876 |
ProPhase Labs Inc | 5.51 |
Applied DNA Sciences Inc | 3.88 |
Veracyte Inc | 20.68 |
Price Related Metrics
PS Ratio | 13.73 |
Price to Book Value | 1.763 |
Earnings Yield | -131.5% |
Market Cap | 36.08M |